Skip to content
RxMonitor home

Medication

Sitagliptin/metformin

DIN 02560461 · Sanis Health Inc Likely a generic

What it is

Active ingredients
Form and route
Tablet · Oral
Schedule
PRESCRIPTION
Authorised since
2026-03-16

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

Products with the same active ingredient

Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

How it is classified

Anatomical main group
Alimentary tract and metabolism
ATC code
A10BD07

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of A10BD07, see the WHO ATC/DDD Index.

Recalls and safety alerts

Recall matching is not available yet.

RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.

Search Health Canada recalls for Sitagliptin/metformin →

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.